Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products primarily for the pediatric market. The Company’s pediatric products, designed to improve the health and well-being of children, are focused in the specific areas of allergy, upper respiratory, including nasal, chest congestion and cough, antibiotics and dermatology, including head lice, and contact dermatitis.
- 05/10/2013 PERNIX THERAPEUTICS REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS
- 03/18/2013 PERNIX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2012 FINANCIAL RESULTS
- 03/07/2013 Pernix Therapeutics Completes Acquisition of Somaxon Pharmaceuticals, Inc.
|Founded in 1997, the Company is headquartered in The Woodlands, TX. Pernix Therapeutics Holdings, Inc. (PTX) is listed and publicly traded on the NYSE Amex.|